September 14,Singapore
Dr. Milind AntaniHead, Pharma & Life Science Practice
© Nishith Desai Associates www.nishithdesai.com
Overview
• Various Drug Laws…..General
• Various Drug Laws…..Specific
• Medical Devices/Equipments– Regulatory Procedural Requirements– Import Procedure– Recent Developments
• Take Away & Experience Sharing
2© Nishith Desai Associates
Various Drug Laws…..General
3© Nishith Desai Associates
Various Drug Laws
4© Nishith Desai Associates
Laws
Various regulatory aspects related to import, manufacture, sale and advertisements related to drugs are covered under three separate enactments, namely,
• Drugs & Cosmetics Act, 1940 and the Drugs & Cosmetics Rules 1945, • The Pharmacy Act, 1948 and • The Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954.
–Other guidelines / Acts–Agencies/Authorities
5
6
Drugs and Cosmetics Act, 1940 & Drugs and Cosmetics Rules, 1945
The main objective of the Act is to ensure that the drugs available to the people are safe and efficacious and conform to prescribed quality standards and the cosmetics marketed are safe for use.Scope
•Approval of New Drugs•Import of new drugs•Manufacturing of New drugs•License to Market•Clinical Trials in the country •Laying down the standards for Drugs •Control over the quality of imported Drugs •Prohibition –
Misbranded, Adulterated, Spurious Drugs and Cosmetics50 Forms40 Schedules The Drugs Controller General of India (“DCGI”) is the apex statutory,
executive and quasi-judicial body at the Central level under the Act and the Rules.
6
7
Approval Process ( New Drug )
Dug Approval
Manufacture Sale and Distribution Import of New Drug Clinical Trial
Rules: 122 BSchedule M
Form 44
Rules: Rule 59 Form No: 19
Rules: 122-AForms: 44 and 9
Schedule Y :Good Clinical Practices
Form 44
Foreign Company Domestic Agent
DCGI
7
Amended checklist for test license applications effective from 15 June 2011
Various Drug Laws…Specific
8© Nishith Desai Associates
99
Manufacturing• License to Manufacture Drugs• Industrial Licensing • GMP• Other important approvals / licenses
1010
Marketing and Distribution
• Licensing of sales outlets/ stocking points,
• OTC and ethical drugs
• Advertising and promotion
• Packaging and labeling
• Distribution methods
• Brand names
• Restrictive trade practices
• Consumer protection• The Shops and Establishment Act
•The Standard Of Weights And Measures Act
• Labor legislation
• Sales tax
1111
Clinical Trials
• Rules 122 DA to 122 E of Drugs and Cosmetic Rules read along with Drugs and Cosmetics Act
• Rule 122 DAA: defines the term “Clinical Trial”
a systematic study of new drug(s)human subject(s) safety and/or efficacy of the new drug.”
• Rule 122 E New Drug
not been used in the country to any significant extentnot been recognized as effective and safe
• Schedule
Y
to the Rules: Good Clinical Practices • ICMR Guidelines
• ICH Guidelines
• Schedule Y1
1212
Health Care –
Hospitals / Labs etc..
• Private Hospitals
• Corporate Hospitals
• Diagnostic Laboratories
• Diagnostic Clinics
• Blood Banks
• Radiotherapy Centers etc– All general approvals
– Approval under PNDT Act
– Disposal of Biomedical waste
– Specific approval for Blood banks
– Permissions from BARC
– Other local approvals
1313
Non-complianceNon-compliance of the following under Drugs Act and Rules norms can trigger cancellation of License
Data Integrity and Reporting: It is important that the data that is submitted by the sponsors and upon which regulators rely, must be complete and accurate as per the requirements of DC Rules.
• Procuring a Proper License: DC Act mandates that the clinical research has to be conducted according to the conditions specified in license and thus conducting clinical research not authorised by the license would attract penal consequences.
• Importing and Manufacturing Permissions:Rule 122-A provides that no drug could be imported or manufactured for a clinical trial without obtaining a proper license. Thus it is important that a valid license should be obtained in order to produce or import right medicine so as to avoid any liability.
1414
Non-compliance
• Absence of Informed ConsentIf consent of the Subject is procured by coercion, undue influence or inducement, or intimidation , the Investigator may be held liable.
• Breach of ProtocolSchedule Y mandates that the Protocol should describe how protocol violations will be treated, including conditions where the study
will be terminated for non-compliance with the protocol.
Medical Devices /Equipments
15© Nishith Desai Associates
Devices/Equipments
16© Nishith Desai Associates
Notified Medical Devices
17© Nishith Desai Associates
Notified Medical Devices
18© Nishith Desai Associates
Notified Medical Devices….clarification
• Spinal Needles• Insulin Syringes• Three Way Stop Cock as an accessory
of I.V.Cannula/Catheter/Perfusion Set
• Endotracheal tubes• Introducer Sheath• Annuloplasty Ring• Cardiac Patch• Cochlear Implant • Extension Tube• Close Wound Drainage Set• Trachestomy Tube with / without
Cuff
• AV Fistula Needle• Extension Line as a accessory of
Infusion Set• ANGO kit/PTCA/Cath Lab Kit• Heart Lung Pack• Measure Volume Set• Flow Regulator as a accessory of
Infusion Set• Hemodialysis Tubing Set / Blood
Tubing Set/Arterial Venous Tubing Set
• Dialysis Catheter
Clarification with regard to control of various medical devices (dated : 20.03.2009)
19© Nishith Desai Associates
Drug
Sec 3 (b) (iv) of the Drugs & Cosmetic Act.
“
such devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the Central Government by notification
in the Official Gazette, after consultation with
the Board ”
20© Nishith Desai Associates
Regulatory Procedural Requirements
21© Nishith Desai Associates
Modes of BusinessImport Of Medical Devices
• For the purpose of import of the regulated devices, the procedure for registration and import licence as prescribed under the Drugs and Cosmetics Rules, 1945 are to be followed. The license to import will have to be obtained by the importer and not the manufacturer.
Manufacture of medical devices in the country
• An application for the grant of licence is required to be made in a stipulated form to the State Licensing Authority, accompanied by
the requisite fee in the form and manner as prescribed in the Rules,
along with a copy marked to the office of the DCGI.
Sale of medical devices in the country
• The importers, stockiest and retail sellers of the specified devices will be required to obtain appropriate sale licences from the State Licensing Authorities.
22© Nishith Desai Associates
Regulatory Requirements
Licenses & Approvals:•
License to sell, stock, exhibit or offer for sale or distribute drugs (Wholesale License)
•
Registration Certificate for the medical device •
Import License
23© Nishith Desai Associates
Regulatory ProcedureImport License
Formality• Application under Form 40 to be filed for the grant of Registration
Certificate
in respect of the premises and the devices manufactured by the manufacturer and meant for import.
• An application in Form 8
to be filed for license to import drugs into India. There are associated registration fees.
• The copies of Whole Sale Drug Licence on Form 20-B and 21-B issued by the respective State Licensing Authority (SLA) should be submitted alongwith the application for the purpose of import registration.
24© Nishith Desai Associates
Regulatory ProcedureImport License
The information and documents required to be submitted• Details of the standards followed by the manufacturer for good
manufacturing practices and product evaluation. • Details pertaining to the qualitative and quantitative
particulars of the constituents of such medical devices.
• Brief description of the method of manufacture and specifications of the materials used and information on the stability of such medical devices.
• List of accessories
and other devices or equipment to be used in combination with the device. Other descriptive information, including accessories packaged with the product.
• Details of standards to which the device conform along with the copy of the standard.
25© Nishith Desai Associates
Regulatory ProcedureImport License
Regulatory Status:• Approval of the product from any other regulatory agency (Separate
evidence for the approval from the each agency)• US FDA clearance/approval.• EU medical device directive (CE Certificate).• Australia/Canada/Japan approval.• Approval
in any other country. – Copy of ISO/EN Certification if any for the manufacturing facility.– List of countries where the device is being sold.– List of countries where device is withdrawn from sale with reasons, if any.
26© Nishith Desai Associates
Regulatory Procedure
27© Nishith Desai Associates
Regulatory Procedure
28© Nishith Desai Associates
Import Procedure
29© Nishith Desai Associates
Import Procedure
• Importer and Exporter Code (“IEC”) Number from the office of the Director General of Foreign Trade (“DGFT”).
• The IEC Number would be required to be mentioned in the documents filed with Customs for clearance of imported goods.
• Clearance is usually undertaken by the Customs House Agent (“CHA”) who can be appointed for this task. The duty would be required to be paid, within 5 days.
• All medical equipments (with some exceptions) will attract 5% basic customs duty, 4% CVD/excise duty and Nil special additional duty of customs [i.e. effective duty of 9.2%].
30© Nishith Desai Associates
Medical Devices..Recent Developments
31© Nishith Desai Associates
Recent Developments
1.
Guidance document on application for grant of Licence in Form-28 for manufacture
of Medical Devices in India
under Central Licensing Approval Authority (CLAA) Scheme;
2.
Guidance Document on Common Submission Format for Registration
of Medical Devices in India;
3.
Guidance Document on Common Submission Format for Import Licence
in Form 10 of Medical Devices in India;
4.
Requirements for Conducting Clinical Trial(s) of Medical Devices in India.
32© Nishith Desai Associates
The Medical Devices Regulation Bill, 2006
• Establishment of Medical Device Regulatory Authority Of India (MDRA)• Classification of medical devices• Medical device standards• Conformity assessment and placing on the market• Import of medical devices• Refurbished and date expired medical devices• Vigilance by MDRA• Enforcement • Medical device safety appellate tribunal• Offences and penalties
33© Nishith Desai Associates
Take Away & Experience Sharing
34© Nishith Desai Associates
Take Aways
35© Nishith Desai Associates
Thank You [email protected]